This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GreeneStone Healthcare Announces Fiscal 2012 Financial Results, Revenues Up 230%

TORONTO, April 2, 2013 (GLOBE NEWSWIRE) -- GreeneStone Healthcare Corporation (OTCBB:GRST) (the "Company") provider of healthcare services and operator of addiction treatment clinics, today announces fiscal year 2012 financial results. For the twelve months ending Dec. 31, 2012, the Company reported total revenues increase of 230% to $5,540,909, as compared to $1,678,804 for same period in 2011. For the same twelve-month period, the Company reported total net loss of ($1,553,797), or ($0.08) EPS, compared to ($2,462,288), or ($0.34) EPS for the same period ending in 2011.

This increase in revenue was mainly attributable to a steady increase in business volume since the Company began operations. The Company believes that revenue growth will continue to increase steadily and the Company will become more profitable as most of its costs, such as rent and salaries and wages are relatively fixed, and therefore will reduce, as a percentage, as business and bed capacity volume grows. Net Loss

During the year ended December 31, 2012, the net loss decreased to $1,553,797 from $2,462,288 during the year ended December 31, 2011, a decrease of $908,491. This reduction is attributable to the steady increase in revenues and will become more profitable as revenues continue to grow as the company can take advantage of economies of scale as most of its costs rent salaries and wages are relatively fixed. Shawn Leon, president and chief executive officer of GreeneStone Healthcare Corporation, commented, "The Company expected this operational results for the fiscal year 2012, and we anticipate even stronger growth in 2013 where we have all the reasons to believe that by the end of our second quarter the Company will be profitable."

Additional information may be found in the Company's 10-K filing with the U.S. Securities and Exchange Commission.
 
GREENESTONE HEALTHCARE CORPORATION
CONSOLIDATED STATEMENT OF OPERATIONS
FOR THE YEAR ENDED DECEMBER 31, 2012
(Stated in U.S. $)
 
  December 31, 2012 December 31, 2011
REVENUES $5,540,909 $1,678,804
COST OF SERVICES PROVIDED 1,050,002 648,773
GROSS PROFIT 4,490,907 1,030,031
     
OPERATING EXPENSES    
Continuing education 25,739 7,049
Depreciation 223,984 129,766
General and administrative 546,563 510,147
Interest and fees 214,207 26,568
Management fees (note 10) 179,924 461,895
Meals and entertainment 3,385 1,462
Medical supplies 132,253 81,139
Professional fees 128,578 434,804
Rent (note 10) 847,558 465,035
Salaries and wages 3,410,659 1,532,678
Subcontract fees 42,890 9,386
Supplies 181,590 72,076
Travel 37,930 16,093
  5,975,260 3,748,098
     
  (1,484,353) (2,718,067)
OTHER INCOME    
Rental income —  221,206
NET LOSS APPLICABLE TO COMMON SHAREHOLDERS $(1,484,353) $(2,496,861)
     
OTHER COMPREHENSIVE INCOME (LOSS)    
Foreign currency translation (69,444) 34,573
     
TOTAL COMPREHENSIVE LOSS $(1,553,797) $(2,462,288)
     
BASIC AND DILUTED LOSS PER COMMON SHARE $(0.08) $(0.34)
WEIGHTED AVERAGE SHARES OUTSTANDING 19,453,717 7,443,626

About GreeneStone Healthcare Corporation

GreeneStone Healthcare Corporation (OTCBB:GRST) (OTCQB:GRST) operates medical and healthcare clinics in Ontario, Canada. GreeneStone's clinics serve to add overflow capacity to an increasingly stretched provincial healthcare system, and provide private alternatives to publicly available healthcare services. Its four medical clinics (three in Toronto, along with a facility in Muskoka, Ontario) offer various medical services, including addiction treatment, endoscopy, minor cosmetic procedures, and executive health care services. The company currently has more than 60 employees and is based in Toronto, Ontario.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASDAQ 4,683.9190 -49.5780 -1.05%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs